Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.070
+0.050 (2.48%)
At close: Aug 21, 2026, 4:00 PM EDT
2.130
+0.060 (2.90%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $374.83 million as of August 21, 2026. Its market cap has increased by 696.11% in one year.
Market Cap
374.83M
Enterprise Value
293.78M
1-Year Change
696.11%
Ranking
Category
Stock Price
$2.07
ChartMarket Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $374.83M, a decrease of -64.34%. That is a compound annual growth rate of -18.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 374.83M | 331.53% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enanta Pharmaceuticals | 392.32M |
| Rocket Pharmaceuticals | 385.31M |
| Arcturus Therapeutics Holdings | 382.29M |
| Upstream Bio | 381.75M |
| Lyell Immunopharma | 380.56M |
| Clinuvel Pharmaceuticals | 376.65M |
| Galectin Therapeutics | 371.13M |
| Palisade Bio | 365.97M |